| Aktie | Ticker | Breite | GCS | 2025/Q3 | |||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 53.189.191 $ | +16.091.717 $ | +32,1 % | 2 | ||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 53.020.254 $ | +16.062.600 $ | +43,5 % | 1 |
| SPDR SERIES TRUST | → 0 | 168.937 $ | +29.117 $ | +20,8 % | 1 | ||
| 53.189.191 $ | +16.091.717 $ | +32,1 % | 2 | ||||